EndoS2 is a unique and conserved enzyme of serotype M49 group A Streptococcus that hydrolyses N-linked glycans on IgG and α1-acid glycoprotein J Sjögren, WB Struwe, EFJ Cosgrave, PM Rudd, M Stervander, M Allhorn, ... Biochemical journal 455 (1), 107-118, 2013 | 121 | 2013 |
A novel mechanism for NETosis provides antimicrobial defense at the oral mucosa T Mohanty, J Sjögren, F Kahn, AHA Abu-Humaidan, N Fisker, K Assing, ... Blood, The Journal of the American Society of Hematology 126 (18), 2128-2137, 2015 | 110 | 2015 |
Rapid and improved characterization of therapeutic antibodies and antibody related products using IdeS digestion and subunit analysis J Sjögren, F Olsson, A Beck Analyst 141 (11), 3114-3125, 2016 | 94 | 2016 |
EndoS and EndoS2 hydrolyze Fc-glycans on therapeutic antibodies with different glycoform selectivity and can be used for rapid quantification of high-mannose glycans J Sjögren, EFJ Cosgrave, M Allhorn, M Nordgren, S Björk, F Olsson, ... Glycobiology 25 (10), 1053-1063, 2015 | 88 | 2015 |
Deciphering Protein O-Glycosylation: Solid-Phase Chemoenzymatic Cleavage and Enrichment S Yang, P Onigman, WW Wu, J Sjögren, H Nyhlen, RF Shen, J Cipollo Analytical chemistry, 2018 | 84 | 2018 |
Structural basis of mammalian mucin processing by the human gut O-glycopeptidase OgpA from Akkermansia muciniphila B Trastoy, A Naegeli, I Anso, J Sjögren, ME Guerin Nature communications 11 (1), 4844, 2020 | 65 | 2020 |
Study of the IgG endoglycosidase EndoS in group A streptococcal phagocyte resistance and virulence J Sjögren, CYM Okumura, M Collin, V Nizet, A Hollands BMC microbiology 11, 1-7, 2011 | 55 | 2011 |
Bacterial glycosidases in pathogenesis and glycoengineering J Sjögren, M Collin Future Microbiology 9 (9), 1039-1051, 2014 | 50 | 2014 |
EndoE from Enterococcus faecalis Hydrolyzes the Glycans of the Biofilm Inhibiting Protein Lactoferrin and Mediates Growth J Garbe, J Sjögren, EFJ Cosgrave, WB Struwe, M Bober, AI Olin, ... PLoS One 9 (3), e91035, 2014 | 49 | 2014 |
On enzymatic remodeling of IgG glycosylation; unique tools with broad applications J Sjögren, R Lood, A Nägeli Glycobiology 30 (4), 254-267, 2020 | 38 | 2020 |
Optimization of O-GIG for O-Glycopeptide Characterization with Sialic Acid Linkage Determination S Yang, WW Wu, R Shen, J Sjogren, L Parsons, JF Cipollo Analytical Chemistry 92 (16), 10946-10951, 2020 | 22 | 2020 |
State-of-the-art native mass spectrometry and ion mobility methods to monitor homogeneous site-specific antibody-drug conjugates synthesis E Deslignière, A Ehkirch, BL Duivelshof, H Toftevall, J Sjögren, ... Pharmaceuticals 14 (6), 498, 2021 | 21 | 2021 |
Glycan-mediated technology for obtaining homogeneous site-specific conjugated antibody–drug conjugates: synthesis and analytical characterization by using complementary middle … BL Duivelshof, E Deslignière, O Hernandez-Alba, A Ehkirch, H Toftevall, ... Analytical chemistry 92 (12), 8170-8177, 2020 | 21 | 2020 |
EndoSd: an IgG glycan hydrolyzing enzyme in Streptococcus dysgalactiae subspecies dysgalactiae A Shadnezhad, A Naegeli, J Sjögren, B Adamczyk, F Leo, M Allhorn, ... Future Microbiology 11 (6), 721-736, 2016 | 21 | 2016 |
Antibody conjugations via Glycosyl remodeling H Toftevall, H Nyhlén, F Olsson, J Sjögren Antibody-Drug Conjugates: Methods and Protocols, 131-145, 2019 | 13 | 2019 |
Generating and purifying Fab fragments from human and mouse IgG using the bacterial enzymes IdeS, SpeB and Kgp J Sjögren, L Andersson, M Mejàre, F Olsson Bacterial Pathogenesis: Methods and Protocols, 319-329, 2016 | 10 | 2016 |
Turning universal O into rare Bombay type blood I Anso, A Naegeli, JO Cifuente, A Orrantia, E Andersson, ... Nature Communications 14 (1), 1765, 2023 | 8 | 2023 |
Endoglycosidase from Streptococcus pyogenes and methods using it M Collin, M Allhorn, J Sjögren US Patent 9,493,752, 2016 | 5 | 2016 |
Multiple modes of action mediate the therapeutic effect of intravenous IgG in experimental epidermolysis bullosa acquisita E Pipi, A Kasprick, H Iwata, S Goletz, JE Hundt, H Sadeghi, ... Journal of Investigative Dermatology 142 (6), 1552-1564. e8, 2022 | 4 | 2022 |
Treatment for IgE-mediated disease M Collin, R Lood, K Carlstrom, M Allhorn, J Sjogren, F Nimmerjahn, ... US Patent App. 14/002,949, 2012 | 3* | 2012 |